Non-Heme Iron Enzymes Catalyze Heterobicyclic and Spirocyclic Isoquinolone Core Formation in Piperazine Alkaloid Biosynthesis

Angew Chem Int Ed Engl. 2024 May 13;63(20):e202401324. doi: 10.1002/anie.202401324. Epub 2024 Apr 9.

Abstract

We report the discovery and biosynthesis of new piperazine alkaloids-arizonamides, and their derived compounds-arizolidines, featuring heterobicyclic and spirocyclic isoquinolone skeletons, respectively. Their biosynthetic pathway involves two crucial non-heme iron enzymes, ParF and ParG, for core skeleton construction. ParF has a dual function facilitating 2,3-alkene formation of helvamide, as a substrate for ParG, and oxidative cleavage of piperazine. Notably, ParG exhibits catalytic versatility in multiple oxidative reactions, including cyclization and ring reconstruction. A key amino acid residue Phe67 was characterized to control the formation of the constrained arizonamide B backbone by ParG.

Keywords: alkaloids; biosynthesis; natural products; non-heme iron-dependent oxygenases; piperazine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids* / biosynthesis
  • Alkaloids* / chemistry
  • Alkaloids* / metabolism
  • Biocatalysis
  • Cyclization
  • Iron / chemistry
  • Iron / metabolism
  • Molecular Structure
  • Oxidation-Reduction
  • Piperazine / chemistry
  • Piperazine / metabolism
  • Piperazines / chemistry
  • Piperazines / metabolism
  • Spiro Compounds / chemistry
  • Spiro Compounds / metabolism

Substances

  • Alkaloids
  • Piperazines
  • Iron
  • Spiro Compounds
  • Piperazine